Utama › Limfoma Sel B Besar Difus › Idaho
Kajian klinikal Limfoma Sel B Besar Difus di Idaho
4 kajian untuk Limfoma Sel B Besar Difus sedang mencari peserta di lokasi di Idaho.
Teks kajian rasmi (Bahasa Inggeris)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Kootenai Clinic Cancer Services - Post Falls, Post Falls
- Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06649812A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Beacon Cancer Care ( Site 0142), Post Falls
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06890884Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- St Luke?s Cancer Institute, Boise
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06806033Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Luke's Cancer Institute - Fruitland, Fruitland
- Saint Luke's Cancer Institute - Meridian, Meridian
- dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Feb 2026 · NCT05633615Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.